1 – 10 of 11
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Lower 68Ga-DOTATOC uptake in nonfunctioning pituitary neuroendocrine tumours compared to normal pituitary gland—A proof-of-concept study
(
- Contribution to journal › Article
- 2019
-
Mark
Bone marrow absorbed doses and correlations with hematological response during 177Lu-DOTATATE treatments are influenced by image-based dosimetry method and presence of skeletal metastases
(
- Contribution to journal › Article
- 2016
-
Mark
Analytical Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize the Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer.
(
- Contribution to journal › Article
- 2013
-
Mark
Progression of bone metastases in patients with prostate cancer - automated detection of new lesions and calculation of bone scan index
(
- Contribution to journal › Article
-
Mark
Bone Scan Index: A prognostic imaging biomarker for high-risk prostate cancer patients receiving primary hormonal therapy
(
- Contribution to journal › Article
- 2012
-
Mark
A Novel Automated Platform for Quantifying the Extent of Skeletal Tumour Involvement in Prostate Cancer Patients Using the Bone Scan Index.
(
- Contribution to journal › Article
- 2011
-
Mark
Relation between pain and skeletal metastasis in patients with prostate or breast cancer.
(
- Contribution to journal › Article
-
Mark
Clinical data do not improve artificial neural network interpretation of myocardial perfusion scintigraphy.
(
- Contribution to journal › Article
- 2008
-
Mark
Normal limits for left ventricular ejection fraction and volumes determined by gated single photon emission computed tomography - a comparison between two quantification methods
(
- Contribution to journal › Article
-
Mark
Evaluation of a decision support system for interpretation of myocardial perfusion gated SPECT
(
- Contribution to journal › Article